Skip to main content
. 2023 Jun 21;7:e2300132. doi: 10.1200/PO.23.00132

FIG 1.

FIG 1.

Schematic overview of clonal expansion of HSCs in CH and the associated clinical consequences of circulating CH-mutant HSC clones. After somatic mutations in a driver gene, the selective advantage created allows the HSC clone to expand in the bone marrow and become overrepresented in the blood, contributing to inflammation and age-related disease while posing a risk of malignant transformation. Created with BioRender.4 CH, clonal hematopoiesis; HSCs, hematopoietic stem cells.